Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jun;7(3):220-7.
doi: 10.1080/13550280152403263.

Viruses can silently prime for and trigger central nervous system autoimmune disease

Affiliations

Viruses can silently prime for and trigger central nervous system autoimmune disease

D J Theil et al. J Neurovirol. 2001 Jun.

Abstract

Although many viruses have been isolated from patients with multiple sclerosis (MS), as yet, no one agent has been demonstrated to cause MS. In contrast, epidemiological data indicate that viral infections are associated with exacerbations of MS. Here, we present data showing that virus infections can subclinically prime animals for central nervous system (CNS) autoimmune disease; long after the original infection has been eradicated, a nonspecific challenge/infection can trigger an exacerbation. The priming infectious agent must show molecular mimicry with self-CNS antigens such as glial fibrillary acidic protein (GFAP), myelin associated glycoprotein (MAG) or myelin proteolipid protein (PLP). The subsequent challenge, however, may be nonspecific; complete Freund's adjuvant (CFA), or infection with a recombinant vaccinia virus encoding an irrelevant protein, could trigger CNS disease. In the CNS, we could detect a mononuclear cell infiltration, but no demyelination was found. However, if the pathogenesis of MS is similar to that of this novel animal model for CNS autoimmune disease, our findings could help explain why exacerbations of MS are often associated with a variety of different viral infections.

PubMed Disclaimer

References

    1. Lab Invest. 1997 Mar;76(3):355-64 - PubMed
    1. J Immunol. 1995 Oct 15;155(8):4046-51 - PubMed
    1. Proc Soc Exp Biol Med. 1966 Nov;123(2):539-41 - PubMed
    1. Neurology. 1986 Oct;36(10):1386-9 - PubMed
    1. J Neuroimmunol. 1982 Dec;3(4):307-18 - PubMed

Publication types

MeSH terms